Richard M. Cohen

October 9, 2026

Ondas shares drop 5% despite $165M in new defense orders. Ondas reported adding $165 million to its order book, which improves visibility for 2027 revenue. However, the stock fell 5% as investors remained cautious about converting these orders into actual earnings. The decline occurred alongside similar drops in peer companies like AeroVironment and Red Cat, suggesting broader sector sentiment is influencing the price.

October 3, 2026

20/20 BioLabs Sets October Dates for FDA Vote and Investor Updates. 20/20 BioLabs has scheduled an investor webinar for October 7, 2026, to discuss an upcoming FDA Advisory Committee vote and its new OneTest franchise model. The company will also take part in the Maxim Growth Summit in New York on October 14, 2026. These events provide key upcoming touchpoints for the stock, which currently trades near its 52-week low.

September 29, 2026

GECC Stock May Be Undervalued, Yahoo Analysis Says. A recent Yahoo article questions whether Great Elm Capital Corp. is undervalued. The piece highlights the company’s low P/E of 0.2, high dividend yield of 13.77%, and a target price of $6.50. It also notes the stock sits near a support level of $5.25 and an RSI of 40.4, suggesting limited short‑term upside. The analysis does not provide a trading recommendation.